Regulatory News has published 1 story about Mirum Pharmaceuticals on 26 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 26 September 2026.
This page is generated from Regulatory News’ editorial coverage of Mirum Pharmaceuticals. It is not an advertisement.
On the record
- Company
- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM)
- Headquarters
- Foster City, California
- Founded
- November 2018, to develop therapies for rare diseases
- Regulator
- U.S. Food and Drug Administration (CDER), Priority Review
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
